NUVEEN AMT-FR QLTY MUNI INC (NEA)

US6706571055

11.18  0 (0%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to NEA. NEA was compared to 0 industry peers in the Unkown industry. NEA scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. NEA has a expensive valuation and it also scores bad on growth.



2

1. Profitability

1.1 Basic Checks

In the past year NEA was profitable.
NEA had a positive operating cash flow in the past year.
Of the past 5 years NEA 4 years were profitable.
In the past 5 years NEA always reported a positive cash flow from operatings.

1.2 Ratios

Industry RankSector Rank
ROA -0.21%
ROE -0.21%
ROIC 1.95%
ROA(3y)-4.42%
ROA(5y)-0.51%
ROE(3y)-4.7%
ROE(5y)-0.62%
ROIC(3y)2.11%
ROIC(5y)2.14%

1.3 Margins

NEA's Profit Margin has declined in the last couple of years.
In the last couple of years the Operating Margin of NEA has declined.
NEA's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 57.58%
PM (TTM) N/A
GM 57.7%
OM growth 3Y-11.62%
OM growth 5Y-6.09%
PM growth 3Y-40.19%
PM growth 5YN/A
GM growth 3Y-11.59%
GM growth 5Y-6.07%

4

2. Health

2.1 Basic Checks

The number of shares outstanding for NEA remains at a similar level compared to 1 year ago.
Compared to 5 years ago, NEA has more shares outstanding
Compared to 1 year ago, NEA has an improved debt to assets ratio.

2.2 Solvency

NEA has an Altman-Z score of 15.78. This indicates that NEA is financially healthy and has little risk of bankruptcy at the moment.
The Debt to FCF ratio of NEA is 0.23, which is an excellent value as it means it would take NEA, only 0.23 years of fcf income to pay off all of its debts.
NEA has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
Even though the debt/equity ratio score it not favorable for NEA, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.23
Altman-Z 15.78
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

NEA has a Current Ratio of 1.12. This is a normal value and indicates that NEA is financially healthy and should not expect problems in meeting its short term obligations.
A Quick Ratio of 1.12 indicates that NEA should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 1.12
Quick Ratio 1.12

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 102.49% over the past year.
NEA shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -41.91% yearly.
The Revenue has been growing slightly by 1.87% in the past year.
Measured over the past years, NEA shows a decrease in Revenue. The Revenue has been decreasing by 0.00% on average per year.
EPS 1Y (TTM)102.49%
EPS 3Y-41.91%
EPS 5YN/A
EPS Q2Q%49.74%
Revenue 1Y (TTM)1.87%
Revenue growth 3Y-0.34%
Revenue growth 5Y0%
Sales Q2Q%-0.14%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

NEA is valuated quite expensively with a Price/Earnings ratio of 93.17.
The average S&P500 Price/Earnings ratio is at 27.73. NEA is valued rather expensively when compared to this.
Industry RankSector Rank
PE 93.17
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF 8.68
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

NEA has a Yearly Dividend Yield of 6.09%, which is a nice return.
Compared to an average S&P500 Dividend Yield of 2.24, NEA pays a better dividend.
Industry RankSector Rank
Dividend Yield 6.09%

5.2 History

The dividend of NEA decreases each year by -8.06%.
NEA has paid a dividend for at least 10 years, which is a reliable track record.
The dividend of NEA decreased recently.
Dividend Growth(5Y)-8.06%
Div Incr Years1
Div Non Decr Years1

5.3 Sustainability

NEA has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-1261.83%
EPS Next 2YN/A
EPS Next 3YN/A

NUVEEN AMT-FR QLTY MUNI INC

NYSE:NEA (12/20/2024, 8:26:44 PM)

11.18

0 (0%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)07-01 2024-07-01
Earnings (Next)01-06 2025-01-06
Inst Owners29.54%
Inst Owner Change-13.35%
Ins Owners0%
Ins Owner Change0%
Market Cap3.34B
Analysts0
Price TargetN/A
Short Float %0.09%
Short Ratio0.26
Dividend
Industry RankSector Rank
Dividend Yield 6.09%
Dividend Growth(5Y)-8.06%
DP-1261.83%
Div Incr Years1
Div Non Decr Years1
Ex-Date12-13 2024-12-13 (0.073)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 93.17
Fwd PE N/A
P/S 12.46
P/FCF 8.68
P/OCF 8.68
P/B 0.54
P/tB 0.54
EV/EBITDA N/A
EPS(TTM)0.12
EY1.07%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.29
FCFY11.52%
OCF(TTM)1.29
OCFY11.52%
SpS0.9
BVpS20.64
TBVpS20.64
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.21%
ROE -0.21%
ROCE 2.47%
ROIC 1.95%
ROICexc 1.95%
ROICexgc 1.95%
OM 57.58%
PM (TTM) N/A
GM 57.7%
FCFM 143.53%
ROA(3y)-4.42%
ROA(5y)-0.51%
ROE(3y)-4.7%
ROE(5y)-0.62%
ROIC(3y)2.11%
ROIC(5y)2.14%
ROICexc(3y)2.11%
ROICexc(5y)2.14%
ROICexgc(3y)2.11%
ROICexgc(5y)2.14%
ROCE(3y)2.67%
ROCE(5y)2.7%
ROICexcg growth 3Y-7%
ROICexcg growth 5Y-5.21%
ROICexc growth 3Y-7.01%
ROICexc growth 5Y-5.21%
OM growth 3Y-11.62%
OM growth 5Y-6.09%
PM growth 3Y-40.19%
PM growth 5YN/A
GM growth 3Y-11.59%
GM growth 5Y-6.07%
F-Score5
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.23
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 2.51
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.12
Quick Ratio 1.12
Altman-Z 15.78
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)102.49%
EPS 3Y-41.91%
EPS 5YN/A
EPS Q2Q%49.74%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)1.87%
Revenue growth 3Y-0.34%
Revenue growth 5Y0%
Sales Q2Q%-0.14%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-20.97%
EBIT growth 3Y-11.91%
EBIT growth 5Y-6.09%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y71%
FCF growth 3Y7.79%
FCF growth 5YN/A
OCF growth 1Y71%
OCF growth 3Y7.79%
OCF growth 5YN/A